Still don't get the accounting methods though, I actually expected quite a bit more than the $1.262M in receipts, was actually envisioning quite a bit more than that from what was known. So really I'm still lost with the whole "good visability" line.
Pfizer completed first stage of the collaboration on the 12th of December 2011 but the payment triggered did not appear in the December quarterly it was carried over instead to the March Quarterly. December quarterly
* Receipts from customers do not include US$1.35m of revenue contracted in the December quarter. This revenue is payable to the Company in the March quarter.
NW also stated in the Melbourne presentation in March that Janssesn/J&J had proivided the largest upfront to date with $1.2M in January.
Should of been significantly higher than $1.262M in receipts ?
PYC Price at posting:
4.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)